OrphanPacific Front

President's Message

Corporate Philosophy

Activities

Who we are

Japan Market Entry

News Release

Notice of Head Office Relocation (Change of Building)

Announcement Regarding the Designation of Glycerol Phenylbutyrate as an Orphan Drug

Announcement of Application for Approval of Glycerol Phenylbutyrate for the Treatment of Urea Cycle Disorder

Announcement of Marketing Authorization Transfer for Rabipur Intramuscular Injection

Updated Who we are

All News Release

We associate with the activities of Rare Disease Day JAPAN and support activities.